TTPH - Tetraphase Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $100.26. This is a potential upside of $100.26 (0%) from yesterday's end of day stock price of $0.

Tetraphase Pharmaceuticals's activity chart (see below) currently has 26 price targets and 27 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.36% with an average time for these price targets to be met of 76.67 days.

Most recent stock forecast was given by KEVIN KEDRA from GABELLI on 07-May-2020. First documented stock forecast 06-Mar-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4 years 6 months 17 days ago
(07-May-2020)

1/2 (50%)

$36.05 (72.09%)

304

Buy

$140

5 years 2 months 20 days ago
(03-Sep-2019)

0/4 (0%)

$69.6 (98.86%)

Buy

$380

5 years 6 months 13 days ago
(10-May-2019)

0/3 (0%)

$224.8 (144.85%)

Buy

6 years 2 months 3 days ago
(20-Sep-2018)

0/3 (0%)

$150.4 (116.05%)

Buy

$140

$137.8 (6263.64%)

$120

6 years 2 months 27 days ago
(28-Aug-2018)

0/3 (0%)

$81.4 (104.62%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TTPH (Tetraphase Pharmaceuticals) average time for price targets to be met?

On average it took 76.67 days on average for the stock forecasts to be realized with a an average price target met ratio 42.36

Which analyst has the current highest performing score on TTPH (Tetraphase Pharmaceuticals) with a proven track record?

ALAN CARR

Which analyst has the most public recommendations on TTPH (Tetraphase Pharmaceuticals)?

Alan Carr has 5 price targets and 6 ratings on TTPH

Which analyst is the currently most bullish on TTPH (Tetraphase Pharmaceuticals)?

Daniel Brims with highest potential upside - $217.8

Which analyst is the currently most reserved on TTPH (Tetraphase Pharmaceuticals)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?